Oncology Institute (TOI) Gains from Investment Securities (2020 - 2025)
Oncology Institute's Gains from Investment Securities history spans 6 years, with the latest figure at $247000.0 for Q4 2025.
- For Q4 2025, Gains from Investment Securities rose 1958.33% year-over-year to $247000.0; the TTM value through Dec 2025 reached $452000.0, up 181.74%, while the annual FY2025 figure was $247000.0, 533.33% up from the prior year.
- Gains from Investment Securities reached $247000.0 in Q4 2025 per TOI's latest filing, up from $150000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q4 2021 to a low of -$39.4 million in Q1 2022.
- Average Gains from Investment Securities over 5 years is -$2.6 million, with a median of $4000.0 recorded in 2021.
- Peak YoY movement for Gains from Investment Securities: tumbled 986100.0% in 2022, then soared 1958.33% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $1.7 million in 2021, then plummeted by 208.98% to -$1.9 million in 2022, then surged by 147.45% to $893000.0 in 2023, then crashed by 98.66% to $12000.0 in 2024, then skyrocketed by 1958.33% to $247000.0 in 2025.
- Per Business Quant, the three most recent readings for TOI's Gains from Investment Securities are $247000.0 (Q4 2025), $150000.0 (Q3 2025), and $53000.0 (Q2 2025).